Literature DB >> 4348179

Effect of prostaglandins E 1 , E 2 and A 2 on vascular resistance and responses to noradrenaline, nerve stimulation and angiotensin in the dog hindlimb.

P J Kadowitz.   

Abstract

1. The relationship between the vasodilator and inhibitory effects of prostaglandin E(1) (PGE(1)), E(2) and A(2) on responses to nerve stimulation, noradrenaline and angiotensin was evaluated in the dog hindlimb preparation.2. PGE(1) and PGE(2) were equipotent as vasodilators in the hindlimb; however, PGE(1) was much more potent as an inhibitor of vasoconstrictor responses to nerve stimulation, noradrenaline and angiotensin.3. PGA(2) and PGE(2) were approximately equal as inhibitors of vasoconstrictor responses to noradrenaline, nerve stimulation and angiotensin; however, PGE(2) was far more potent as a vasodilator.4. Since there is no relationship between the vasodilator and inhibitory effects of PGE(1), E(2) and A(2), and since the inhibitory effect of PGA(2) was present at a time when hindlimb perfusion pressure had returned to control value, it is concluded that the inhibitory action is probably not the result of a physiological antagonism.5. Since each prostaglandin inhibited responses to nerve stimulation and noradrenaline to approximately the same extent and responses to angiotensin were also inhibited, it is suggested that these agents antagonize vasoconstrictor responses by a nonspecific depressant effect on smooth muscle cells.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4348179      PMCID: PMC1666530          DOI: 10.1111/j.1476-5381.1972.tb08136.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  17 in total

1.  Control by prostaglandin E2 of sympathetic neurotrans-mission in the spleen.

Authors:  P Hedqvist
Journal:  Life Sci       Date:  1970-03-01       Impact factor: 5.037

2.  Release of a prostaglandin-like substance into renal venous blood in response to angiotensin II.

Authors:  J C McGiff; K Crowshaw; N A Terragno; A J Lonigro
Journal:  Circ Res       Date:  1970-07       Impact factor: 17.367

3.  Effect of prostaglandin E1 on blood pressure and heart rate in the dog. Prostaglandin and related factors 48.

Authors:  L A Carlson; L Orö
Journal:  Acta Physiol Scand       Date:  1966-05

4.  Influence of prostaglandin E1 on the terminal vascular bed.

Authors:  R Weiner; G Kaley
Journal:  Am J Physiol       Date:  1969-08

5.  The effects of prostaglandins E1 and E2 on the smooth muscle of the dog spleen and on its responses to catecholamines, angiotensin and nerve stimulation.

Authors:  B N Davies; P G Withrington
Journal:  Br J Pharmacol Chemother       Date:  1968-01

6.  The occurrence of prostaglandin E2 in splenic venous blood of the dog following splenic nerve stimulation.

Authors:  B N Davies; E W Horton; P G Withrington
Journal:  Br J Pharmacol Chemother       Date:  1968-01

7.  Prostaglandins released by the spleen.

Authors:  N Gilmore; J R Vane; J H Wyllie
Journal:  Nature       Date:  1968-06-22       Impact factor: 49.962

8.  Inhibition by prostaglandin E1 of noradrenaline release and of effector response to nerve stimulation in the cat spleen.

Authors:  P Hedqvist; J Brundin
Journal:  Life Sci       Date:  1969-04-01       Impact factor: 5.037

9.  Microcirculatory effects of prostaglandins.

Authors:  M G Viguera; F A Sunahara
Journal:  Can J Physiol Pharmacol       Date:  1969-07       Impact factor: 2.273

10.  Cardiovascular effects of prostaglandin E1.

Authors:  J Nakano; J R McCurdy
Journal:  J Pharmacol Exp Ther       Date:  1967-06       Impact factor: 4.030

View more
  7 in total

1.  On the relation between release of prostaglandins and contractility of rabbit splenic capsular strips.

Authors:  A Jobke; B A Peskar; G Hertting
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

2.  Uterine prostaglandin E secretion and uterine blood flow in the pregnant rabbit.

Authors:  R C Venuto; T O'Dorisio; J H Stein; T F Ferris
Journal:  J Clin Invest       Date:  1975-01       Impact factor: 14.808

3.  [Angiotensin-converting enzyme (ACE). Increased serum activities in patients with dermatological diseases (author's transl)].

Authors:  M Raff; H Bardach; M M Müller
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

4.  Prostaglandin actions on the adrenergic nervous system.

Authors:  H G Güllner
Journal:  Klin Wochenschr       Date:  1983-06-01

Review 5.  The zone diet and athletic performance.

Authors:  S N Cheuvront
Journal:  Sports Med       Date:  1999-04       Impact factor: 11.136

6.  Metabolism and inflammatory mediators in the peritendinous space measured by microdialysis during intermittent isometric exercise in humans.

Authors:  H Langberg; D Skovgaard; M Karamouzis; J Bülow; M Kjaer
Journal:  J Physiol       Date:  1999-03-15       Impact factor: 5.182

7.  Vasoconstrictor response to arachidonic acid in the isolated hind limb of the dog.

Authors:  T M Fitzpatrick; M Johnson; P A Kot; P W Ramwell; J C Rose
Journal:  Br J Pharmacol       Date:  1977-02       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.